Streetbeat News

Products Services

BPTH

CAMP

CNSP

EFSH

GME

MBOT

U.S. stocks traded mostly higher with the Nasdaq Composite gaining around 150 points. The S&P Global manufacturing PMI rose to 51.3 in May. Bio-Path Holdings, Microbot Medical, and GameStop saw significant stock price increases, while CalAmp Corp., 1847 Holdings, and CNS Pharmaceuticals experienced notable declines.

Portfolio Pulse from Avi Kapoor

June 03, 2024 | 1:54 pm

ITA

PPA

Boeing Co. (NYSE:BA) is facing ongoing safety issues, including a recent midair panel blowout on a 737 MAX plane. IATA's head, Willie Walsh, urges Boeing to learn from past mistakes. CEO Dave Calhoun will leave by the end of the year. Boeing's market position is impacted by legal actions, production declines, and competition from Airbus SE (OTC:EADSY). Supply chain disruptions are expected to persist until 2025 or 2026. Boeing's stock has dropped 32% this year, and investors can gain exposure through IShares U.S. Aerospace & Defense ETF (BATS:ITA) and Invesco Aerospace & Defense ETF (NYSE:PPA).

Portfolio Pulse from Shivani Kumaresan

June 03, 2024 | 1:50 pm

SNY

DHL Supply Chain is expanding its pharmaceutical logistics operations in France, enhancing its capabilities to support the healthcare sector.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:43 pm

SCHD

TSLA

VLUE

Ford Motor Co (NYSE:F) shares are rising after the company announced advancements in its autonomous driving technology, aiming to offer Level 3 autonomy by 2026. This would allow drivers to take their eyes off the road and hands off the wheel under certain conditions. Ford's BlueCruise system is under investigation by U.S. safety regulators. The company plans to generate recurring revenue through subscription services for these features.

Portfolio Pulse from Shivani Kumaresan

June 03, 2024 | 1:41 pm

KSCP

Knightscope has partnered with EnGoPlanet to develop the K1 Super Tower, a new public safety solution.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:35 pm

VUZI

Vuzix has been selected by AFWERX for a SBIR Phase I contract to develop augmented reality head-mounted displays using waveguide technologies to address challenges faced by the Department of the Air Force.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:31 pm

PGEN

Precigen announced that its Phase 1/2 study for PRGN-2012 in treating Recurrent Respiratory Papillomatosis (RRP) met primary safety and efficacy endpoints. The study showed significant reductions in surgical interventions and durable complete responses in patients. PRGN-2012 was well-tolerated and induced strong immunological responses. A rolling BLA submission is anticipated in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:31 pm

SERV

Serve Robotics (NASDAQ:SERV) has announced the deployment of DriveU.auto's connectivity platform to enhance the performance of its autonomous delivery robots. This move supports Serve's goal to deploy up to 2,000 robots on the Uber Eats platform.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:25 pm

ACN

AIBU

IETC

Accenture (NYSE:ACN) has partnered with Kraken Technologies to accelerate EDF's UK retail business's digital transformation. The collaboration aims to enhance the adoption of smart energy products through an AI-enabled platform. Accenture's senior managing director highlighted the importance of modernizing the digital core for utilities. Additionally, Accenture Song was recently appointed as the global creative and content agency for Randstad NV (OTC:RANJY). Investors can gain exposure to Accenture through ETFs like IETC and AIBU. ACN shares are slightly down premarket.

Portfolio Pulse from Lekha Gupta

June 03, 2024 | 1:24 pm

Guardant Health and Washington University will present a study at the 2024 ASCO meeting highlighting the utility of ctDNA to address racial inequities in the use of targeted therapies and clinical trial enrollment. The study, using the Guardant360® blood test, found that Black patients with PIK3CA mutations in advanced breast cancer were less likely to be enrolled in clinical trials and receive targeted therapy compared to White patients.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:22 pm